There were 24 companies in cities associated with Montgomery County, Maryland, that received 24 FDA inspections in 2025, according to the U.S. Food and Drug Administration (FDA).
This is a 27.3% decrease from the number of companies inspected in the previous year, when 33 companies received 36 inspections.
Most of the companies inspected at the time operate in the Biologics sector. The second most common type of company inspected period worked in the Drugs sector.
There were 18 companies in line with FDA regulations who don’t need to adjust their management operations or regulatory/administrative actions (75%). Five should take voluntary action to correct the organization’s management operations (20.8%). Additionally, one company had to take regulatory and/or administrative actions (4.2%).
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.
| Company Name | Area of Business | Inspection Date | Result |
|---|---|---|---|
| Asefa J. Mekonnen, M.D. | Biologics | 04/17/2025 | No Action Indicated (NAI) |
| ChiRhoClin, Inc. | Drugs | 09/15/2025 | Voluntary Action Indicated (VAI) |
| GCDMV, LLC | Food and Cosmetics | 07/21/2025 | No Action Indicated (NAI) |
| Human Genome Sciences, Inc. | Drugs | 07/31/2025 | Voluntary Action Indicated (VAI) |
| Jonathan B. Cohen, M.D. | Biologics | 08/11/2025 | No Action Indicated (NAI) |
| Laura Tonnetti, Ph. D. | Biologics | 11/21/2025 | No Action Indicated (NAI) |
| Lawrence J. Green, M.D. | Drugs | 12/12/2025 | No Action Indicated (NAI) |
| Longhorn Vaccines And Diagnostics, LLC | Devices | 10/30/2025 | Official Action Indicated (OAI) |
| Lung Bioengineering, Inc. | Devices | 05/06/2025 | No Action Indicated (NAI) |
| Maxim Biomedical, Inc. | Biologics | 05/07/2025 | No Action Indicated (NAI) |
| NIH Donor Center at Fishers Lane | Biologics | 03/06/2025 | No Action Indicated (NAI) |
| National institutes of Health Clinical Center | Biologics | 01/21/2025 | No Action Indicated (NAI) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | Drugs | 07/18/2025 | No Action Indicated (NAI) |
| Peruvian USA Distribution, LLC | Food and Cosmetics | 05/05/2025 | No Action Indicated (NAI) |
| Precigen, Inc. | Biologics | 04/15/2025 | No Action Indicated (NAI) |
| REGENXBIO, Inc. | Biologics | 07/31/2025 | No Action Indicated (NAI) |
| Rapa Therapeutics, LLC | Biologics | 06/02/2025 | Voluntary Action Indicated (VAI) |
| Rebecca A. Kazin, M.D. | Devices | 09/25/2025 | No Action Indicated (NAI) |
| Robert E. Litman, M.D. | Drugs | 03/04/2025 | No Action Indicated (NAI) |
| Scott M. Norberg, D. O. | Biologics | 04/23/2025 | No Action Indicated (NAI) |
| Supernus Pharmaceuticals, Inc. | Drugs | 07/31/2025 | No Action Indicated (NAI) |
| Vemulkonda K. Rao, M.D. | Drugs | 10/29/2025 | Voluntary Action Indicated (VAI) |
| Wearlinq, Inc. | Devices | 11/26/2025 | Voluntary Action Indicated (VAI) |
| William R. Childs, M.D. | Biologics | 09/26/2025 | No Action Indicated (NAI) |
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
